Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes [Phase 3]
Phase 3 long-term safety study of CP-464,005 inhaled insulin in Japanese patients with Type 1 or Type 2 diabetes was terminated; results wer…
-
FDA approval · 2009-10-02FDA Approved: WELCHOL — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' original NDA for Welchol (colesevelam hydrochloride). Welchol is a bile acid sequestrant used to treat…
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses [Phase 1]
Phase I study in healthy volunteers to assess safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4017 after repeated ascendin…
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Insulin Glargine Combination Therapies in Type II Diabetics [Phase 3]
A Phase 3 trial update evaluating insulin glargine combination therapies in Type 2 diabetes has completed. The document reports the study st…
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]
Phase 3 study evaluating BMS-477118 as monotherapy with titration in adults with Type 2 diabetes not controlled by diet and exercise; the tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) [Phase 2]
Phase 2 clinical trial of sitagliptin for type 2 diabetes mellitus has completed enrollment and results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas [Phase 3]
This document reports the completion of a Phase 3 trial evaluating saxagliptin added to sulfonylurea therapy in adults with type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone [Phase 3]
A Phase 3 study assessing saxagliptin in addition to TZD therapy for type 2 diabetes patients not adequately controlled on TZDs; results wer…
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045) [Phase 2]
Phase 2 clinical trial of sitagliptin for glucose-lowering effects in adults with Type 2 diabetes mellitus has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]
A Phase 3 trial tested BMS-477118 in combination with metformin in adults with Type 2 diabetes not controlled with diet and exercise. The st…
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED) [Phase 3]
A completed Phase 3 trial evaluating sitagliptin for type 2 diabetes mellitus patients with inadequate glycemic control on diet and exercise…
-
CLINICAL_TRIALS research · 2009-09-24Clinical Trial Update: A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 clinical study of GRC 8200 for Type 2 Diabetes Mellitus is being conducted, with current status not specified.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus [Phase 3]
Phase 3 trial update examining the effect of Januvia on beta cell function in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 study evaluating anti-inflammatory effects of valsartan in patients with type 2 diabetes mellitus; the trial also involves hypertens…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes [Phase 1]
Phase 1 trial comparing oral insulin with subcutaneous regular human insulin in patients with Type 2 diabetes has completed. The study was s…
-
FDA approval · 2009-09-22FDA Approved: GLIMEPIRIDE — Original Application (Carlsbad Technology, Inc.)
The FDA approves the original abbreviated new drug application for GLIMEPIRIDE from Carlsbad Technology, Inc., enabling a generic version of…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation [NA]
A completed clinical trial evaluated whether a green tea preparation high in epigallocatechin gallate (EGCG) influences postprandial fat oxi…
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial comparing mitiglinide plus metformin versus metformin alone in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Phase 1 study from AstraZeneca assessing absorption, distribution, metabolism, and excretion of AZD1656 in individuals with Type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine? [Phase 4]
A Phase 4 trial examining how pioglitazone might reduce protein loss in urine in people with type 2 diabetes; the current status of the stud…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial update evaluating insulin glulisine, insulin lispro, and insulin glargine in adults with Type 1 or Type 2 diabetes; t…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Lantus Versus Levemir Treat-To-Target [Phase 4]
Phase 4 trial comparing Lantus (insulin glargine) and Levemir (insulin detemir) using a treat-to-target approach in Type 2 diabetes. The stu…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Insulin Glargine in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update reporting the completion of a study evaluating insulin glargine in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Insulin Glulisine in Diabetes Mellitus, Type 2 [Phase 3]
A Phase 3 clinical trial evaluating insulin glulisine in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Insulin Glargine in Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update on insulin glargine for Type 2 diabetes mellitus. The study status is COMPLETED.